{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,25]],"date-time":"2025-05-25T19:40:08Z","timestamp":1748202008373,"version":"3.41.0"},"reference-count":43,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,5]]},"abstract":"<jats:p>Tumors of the central nervous system (CNS) in pediatric patients have undergone significant diagnostic refinement through the use of immunohistochemistry (IHC) and molecular techniques. The utility of these novel IHC antibodies has been demonstrated with the inactivation of the switch\/sucrose nonfermenting (SWI\/SNF) chromatin-remodeling complex in the diagnosis of atypical teratoid\/rhabdoid tumors, predominantly through the loss of integrase interactor 1 (INI1; <jats:italic toggle=\"yes\">SMARCB1<\/jats:italic>). Alternatively, these tumors may have inactivation of brahma-related gene 1 (BRG1; <jats:italic toggle=\"yes\">SMARCA4<\/jats:italic>) in a subset of cases. The role of other SWI\/SNF component proteins and their expression in pediatric brain tumors is not well established. Nestin, an intermediate filament, has been shown to be present in some pediatric CNS tumors, but of uncertain diagnostic and prognostic significance. We sought to explore the immunohistochemical expression profile for common SWI\/SNF subunits and nestin in a pediatric CNS tumor cohort. Using a 118-sample tissue microarray, we performed IHC for INI1, BRG1, brahma (BRM), ARID1A, ARID1B, polybromo 1, and nestin. In 19 cases, INI1 was lost and BRG1 was lost in 2 cases. Interestingly, 6 cases originally diagnosed as primitive neuroectodermal tumors showed isolated loss of BRM. Other SWI\/SNF proteins did not provide further diagnostic resolution. Nestin was positive in 76.2% of INI1\/BRG1-deficient tumors, compared with 29.1% in INI1\/BRG1-intact tumors yielding a sensitivity of 76.2%, specificity of 68.0%, and a <jats:italic toggle=\"yes\">P<\/jats:italic> value of &lt;0.001, but nestin positivity did not correlate specifically with poor outcomes. In conclusion, we confirm the utility of BRG1 IHC in the workup of pediatric CNS tumors, which may facilitate a difficult diagnosis when conventional markers are inconclusive, or as a first-line marker in cases where intraoperative smears are suggestive of atypical teratoid\/rhabdoid tumor. Although nestin expression was associated with SWI\/SNF inactivation, it did not yield statistically significant diagnostic or prognostic information in our study. Interestingly, we identified 6 tumors with isolated BRM IHC loss, the significance of which is uncertain but warrants further investigation.<\/jats:p>","DOI":"10.1097\/pai.0000000000001122","type":"journal-article","created":{"date-parts":[[2023,4,10]],"date-time":"2023-04-10T15:00:37Z","timestamp":1681138837000},"page":"304-310","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Characterization of Switch\/Sucrose Nonfermenting Complex Proteins and Nestin Expression in a Cohort of Pediatric Central Nervous System Tumors"],"prefix":"10.1097","volume":"31","author":[{"given":"Xiu Qing","family":"Wang","sequence":"first","affiliation":[{"name":"Department of Pathology and Laboratory Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Basile","family":"Tessier-Cloutier","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine"},{"name":"Department of Pathology and Laboratory Medicine, Vancouver General Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jessica","family":"Saunders","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine"},{"name":"Division of Anatomical Pathology, British Columbia Children\u2019s Hospital and Women\u2019s Health Center, Vancouver, BC, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melissa","family":"Harvey","sequence":"additional","affiliation":[{"name":"Division of Pediatric Hematology\/Oncology\/BMT, British Columbia Children\u2019s Hospital, and Department of Pediatrics"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linlea","family":"Armstrong","sequence":"additional","affiliation":[{"name":"Provincial Medical Genetics Program, British Columbia Children\u2019s Hospital and Women\u2019s Health Center, and Department of Medical Genetics, University of British Columbia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tony","family":"Ng","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine"},{"name":"Department of Pathology and Laboratory Medicine, Vancouver General Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher","family":"Dunham","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine"},{"name":"Division of Anatomical Pathology, British Columbia Children\u2019s Hospital and Women\u2019s Health Center, Vancouver, BC, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan W.","family":"Bush","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine"},{"name":"Division of Anatomical Pathology, British Columbia Children\u2019s Hospital and Women\u2019s Health Center, Vancouver, BC, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2023,4,10]]},"reference":[{"key":"R1-20250525","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1097\/00043426-200206000-00004","article-title":"Atypical teratoid\/rhabdoid tumor of the central nervous system: report on workshop","volume":"24","author":"Packer","year":"2002","journal-title":"J Pediatr Hematol Oncol"},{"key":"R2-20250525","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s11060-016-2353-0","article-title":"Atypical teratoid rhabdoid tumor in the first year of life: the Canadian ATRT registry experience and review of the literature","volume":"132","author":"Fossey","year":"2017","journal-title":"J Neurooncol"},{"key":"R3-20250525","doi-asserted-by":"crossref","first-page":"2877","DOI":"10.1200\/JCO.2004.07.073","article-title":"Central nervous system atypical teratoid\/rhabdoid tumor: results of therapy in children enrolled in a registry","volume":"22","author":"Hilden","year":"2004","journal-title":"J Clin Oncol"},{"key":"R4-20250525","doi-asserted-by":"crossref","first-page":"3812","DOI":"10.1002\/cncr.26684","article-title":"Clinicopathologic prognostic factors in childhood atypical teratoid and rhabdoid tumor of the central nervous system","volume":"118","author":"Dufour","year":"2012","journal-title":"Cancer"},{"key":"R5-20250525","doi-asserted-by":"crossref","first-page":"14648","DOI":"10.1038\/ncomms14648","article-title":"The SWI\/SNF chromatin remodelling complex is required for maintenance of lineage specific enhancers","volume":"8","author":"Alver","year":"2017","journal-title":"Nat Commun"},{"key":"R6-20250525","doi-asserted-by":"crossref","first-page":"412","DOI":"10.4161\/cbt.8.5.8019","article-title":"The role of SMARCB1\/INI1 in development of rhabdoid tumor","volume":"8","author":"Roberts","year":"2009","journal-title":"Cancer Biol Ther"},{"key":"R7-20250525","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1038\/ng.2628","article-title":"Proteomic and bioinformatic analysis of mammalian SWI\/SNF complexes identifies extensive roles in human malignancy","volume":"45","author":"Kadoch","year":"2013","journal-title":"Nat Genet"},{"key":"R8-20250525","doi-asserted-by":"crossref","first-page":"49","DOI":"10.2350\/14-07-1531-MISC.1","article-title":"Rhabdoid tumor predisposition syndrome","volume":"18","author":"Sredni","year":"2015","journal-title":"Pediatr Dev Pathol"},{"key":"R12-20250525","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1097\/PAS.0b013e3182196a39","article-title":"Nonsense mutation and inactivation of SMARCA4 (BRG1) in an atypical teratoid\/rhabdoid tumor showing retained SMARCB1 (INI1) expression","volume":"35","author":"Hasselblatt","year":"2011","journal-title":"Am J Surg Pathol"},{"key":"R13-20250525","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1111\/neup.12452","article-title":"Atypical teratoid\/rhabdoid tumor with retained INI1 (SMARCB1) expression and loss of BRG1 (SMARCA4)","volume":"38","author":"Bookhout","year":"2018","journal-title":"Neuropathology"},{"key":"R14-20250525","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/s00401-020-02250-7","article-title":"Atypical teratoid\/rhabdoid tumors (ATRTs) with SMARCA4 mutation are molecularly distinct from SMARCB1-deficient cases","volume":"141","author":"Holdhof","year":"2021","journal-title":"Acta Neuropathol"},{"key":"R15-20250525","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.ajhg.2010.01.013","article-title":"Germline nonsense mutation and somatic inactivation of SMARCA4\/BRG1 in a family with rhabdoid tumor predisposition syndrome","volume":"86","author":"Schneppenheim","year":"2010","journal-title":"Am J Hum Genet"},{"key":"R16-20250525","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/366170a0","article-title":"BRG1 contains a conserved domain of the SWI2\/SNF2 family necessary for normal mitotic growth and transcription","volume":"366","author":"Khavari","year":"1993","journal-title":"Nature"},{"key":"R17-20250525","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1002\/path.4633","article-title":"Dual loss of the SWI\/SNF complex ATPases SMARCA4\/BRG1 and SMARCA2\/BRM is highly sensitive and specific for small cell carcinoma of the ovary, hypercalcemic type","volume":"238","author":"Karnezis","year":"2016","journal-title":"J Pathol"},{"key":"R18-20250525","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1097\/PAS.0000000000001375","article-title":"SMARCA4-deficient uterine sarcomas and undifferentiated endometrial carcinomas are distinct clinicopathologic entities","volume":"44","author":"Kolin","year":"2020","journal-title":"Am J Surg Pathol"},{"key":"R19-20250525","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1097\/PAS.0000000000000554","article-title":"SWI\/SNF complex-deficient undifferentiated\/rhabdoid carcinomas of the gastrointestinal tract: a series of 13 cases highlighting mutually exclusive loss of SMARCA4 and SMARCA2 and frequent co-inactivation of SMARCB1 and SMARCA2","volume":"40","author":"Agaimy","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"R20-20250525","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1038\/modpathol.2017.61","article-title":"SMARCA4-deficient thoracic sarcoma: a distinctive clinicopathological entity with undifferentiated rhabdoid morphology and aggressive behavior","volume":"30","author":"Sauter","year":"2017","journal-title":"Mod Pathol"},{"key":"R21-20250525","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1053\/j.semdp.2020.05.005","article-title":"SWI\/SNF complex-deficient soft tissue neoplasms: an update","volume":"38","author":"Schaefer","year":"2021","journal-title":"Semin Diagn Pathol"},{"key":"R22-20250525","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1177\/1093526619869154","article-title":"Loss of BRG1 (SMARCA4) immunoexpression in a pediatric non-central nervous system tumor cohort","volume":"23","author":"Saunders","year":"2020","journal-title":"Pediatr Dev Pathol"},{"key":"R23-20250525","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/s00401-014-1323-x","article-title":"SMARCA4-mutated atypical teratoid\/rhabdoid tumors are associated with inherited germline alterations and poor prognosis","volume":"128","author":"Hasselblatt","year":"2014","journal-title":"Acta Neuropathol"},{"key":"R24-20250525","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1016\/j.cell.2018.09.032","article-title":"Modular organization and assembly of SWI\/SNF family chromatin remodelling complexes","volume":"175","author":"Mashtalir","year":"2018","journal-title":"Cell"},{"key":"R25-20250525","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/s41571-020-0357-3","article-title":"The SWI\/SNF complex in cancer\u2014biology, biomarkers and therapy","volume":"17","author":"Mittal","year":"2020","journal-title":"Nat Rev Clin Oncol"},{"key":"R27-20250525","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1038\/jid.2012.508","article-title":"Inhibition of the stem cell marker nestin reduces tumor growth and invasion of malignant melanoma","volume":"133","author":"Akiyama","year":"2013","journal-title":"J Invest Dermatol"},{"key":"R28-20250525","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.mcn.2010.05.006","article-title":"Nestin is essential for mitogen-stimulated proliferation of neural progenitor cells","volume":"45","author":"Xue","year":"2010","journal-title":"Mol Cell Neurosci"},{"key":"R29-20250525","doi-asserted-by":"crossref","first-page":"4808","DOI":"10.1038\/sj.emboj.7601366","article-title":"A nestin scaffold links Cdk5\/p35 signaling to oxidant-induced cell death","volume":"25","author":"Sahlgren","year":"2006","journal-title":"EMBO J"},{"key":"R30-20250525","doi-asserted-by":"crossref","first-page":"3310","DOI":"10.1523\/JNEUROSCI.05-12-03310.1985","article-title":"Identification of major cell classes in the developing mammalian nervous system","volume":"5","author":"Hockfield","year":"1985","journal-title":"J Neurosci"},{"key":"R31-20250525","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.surneu.2006.10.050","article-title":"Neural stem cell markers, nestin and musashi proteins, in the progression of human glioma: correlation of nestin with prognosis of patient survival","volume":"68","author":"Strojnik","year":"2007","journal-title":"Surg Neurol"},{"key":"R32-20250525","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1111\/j.1600-0560.2006.00627.x","article-title":"Nestin expression in cutaneous melanomas and melanocytic nevi","volume":"34","author":"Brychtova","year":"2007","journal-title":"J Cutan Pathol"},{"key":"R33-20250525","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1111\/j.1750-3639.2012.00600.x","article-title":"Nestin expression identifies ependymoma patients with poor outcome","volume":"22","author":"Milde","year":"2012","journal-title":"Brain Pathol"},{"key":"R34-20250525","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1177\/002215540205000203","article-title":"Immunohistochemical detection of nestin in pediatric brain tumors","volume":"50","author":"Almqvist","year":"2002","journal-title":"J Histochem Cytochem"},{"key":"R35-20250525","first-page":"1","article-title":"Oncogene-dependent function of BRG1 in hepatocarcinogenesis","volume":"11","author":"Wang","year":"2020","journal-title":"Cell Death Dis"},{"key":"R36-20250525","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/nature14122","article-title":"EZH2 inhibition sensitizes BRG1 and EGFR mutant lung tumours to TopoII inhibitors","volume":"520","author":"Fillmore","year":"2015","journal-title":"Nature"},{"key":"R37-20250525","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1158\/1535-7163.MCT-18-0067","article-title":"Targeting of BRM sensitizes BRG1-mutant lung cancer cell lines to radiotherapy","volume":"18","author":"Zernickel","year":"2019","journal-title":"Mol Cancer Ther"},{"key":"R38-20250525","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1128\/MCB.01372-13","article-title":"Residual complexes containing SMARCA2 (BRM) underlie the oncogenic drive of SMARCA4 (BRG1) mutation","volume":"34","author":"Wilson","year":"2014","journal-title":"Mol Cell Biol"},{"key":"R39-20250525","doi-asserted-by":"crossref","first-page":"5508","DOI":"10.1158\/0008-5472.CAN-12-4593","article-title":"A synthetic lethality-based strategy to treat cancers harboring a genetic deficiency in the chromatin remodeling factor BRG1","volume":"73","author":"Oike","year":"2013","journal-title":"Cancer Res"},{"key":"R40-20250525","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-019-48152-x","article-title":"SMARCA2-deficiency confers sensitivity to targeted inhibition of SMARCA4 in esophageal squamous cell carcinoma cell lines","volume":"9","author":"Ehrenh\u00f6fer-W\u00f6lfer","year":"2019","journal-title":"Sci Rep"},{"key":"R41-20250525","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1016\/j.humpath.2014.06.027","article-title":"Concurrent loss of INI1, PBRM1, and BRM expression in epithelioid sarcoma: Implications for the cocontributions of multiple SWI\/SNF complex members to pathogenesis","volume":"45","author":"Li","year":"2014","journal-title":"Hum Pathol"},{"key":"R42-20250525","doi-asserted-by":"crossref","first-page":"2492","DOI":"10.1038\/onc.2009.121","article-title":"The SWI\/SNF chromatin remodeling subunit BRG1 is a critical regulator of p53 necessary for proliferation of malignant cells","volume":"28","author":"Naidu","year":"2009","journal-title":"Oncogene"},{"key":"R43-20250525","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1002\/ijc.25586","article-title":"Inducible expression of stem cell associated intermediate filament nestin reveals an important role in glioblastoma carcinogenesis","volume":"128","author":"Lu","year":"2011","journal-title":"Int J Cancer"},{"key":"R44-20250525","doi-asserted-by":"crossref","first-page":"9199","DOI":"10.1158\/0008-5472.CAN-07-0806","article-title":"Roles for the stem cell-associated intermediate filament nestin in prostate cancer migration and metastasis","volume":"67","author":"Kleeberger","year":"2007","journal-title":"Cancer Res"},{"key":"R45-20250525","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1158\/0008-5472.CAN-05-4571","article-title":"Nestin is expressed in the basal\/myoepithelial layer of the mammary gland and is a selective marker of basal epithelial breast tumors","volume":"67","author":"Li","year":"2007","journal-title":"Cancer Res"},{"key":"R46-20250525","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1034\/j.1600-0463.2002.100608.x","article-title":"Patterns of nestin and other intermediate filament expression distinguish between gastrointestinal stromal tumors, leiomyomas and schwannomas","volume":"110","author":"Sarlomo-Rikala","year":"2002","journal-title":"APMIS"},{"key":"R47-20250525","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1093\/neuonc\/noz235","article-title":"Molecular subgrouping of atypical teratoid\/rhabdoid tumors - a reinvestigation and current consensus","volume":"22","author":"Ho","year":"2020","journal-title":"Neuro Oncol"}],"container-title":["Applied Immunohistochemistry &amp; Molecular Morphology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/PAI.0000000000001122","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,25]],"date-time":"2025-05-25T19:02:23Z","timestamp":1748199743000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/PAI.0000000000001122"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,10]]},"references-count":43,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/pai.0000000000001122","relation":{},"ISSN":["1541-2016"],"issn-type":[{"type":"print","value":"1541-2016"}],"subject":[],"published":{"date-parts":[[2023,4,10]]},"assertion":[{"value":"2021-12-23","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-03-09","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}